A sensitive enzyme immunoassay for the quantitation of human CTLA4Ig fusion protein in mouse serum: pharmacokinetic application to optimizing cell line selection
- 28 February 1997
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 15 (5) , 571-579
- https://doi.org/10.1016/s0731-7085(96)01884-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Potential Roles of the B7 and CD28 Receptor Families in Autoimmunity and Immune EvasionClinical Immunology and Immunopathology, 1995
- Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunityBlood, 1994
- Immunosuppression and the CD28 receptorPerspectives in Drug Discovery and Design, 1994
- Blockade of the CD28 co-stimulatory pathway: a means to induce toleranceCurrent Opinion in Immunology, 1994
- Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biologyCurrent Opinion in Immunology, 1993
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapyCell, 1992
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990